Kymera Therapeutics Inc

NASDAQ:KYMR   4:00:00 PM EDT
28.15
-0.66 (-2.29%)
4:02:23 PM EDT: $28.15 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.55B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$14.15 Million
Adjusted EPS-$0.68
See more estimates
10-Day MA$29.30
50-Day MA$32.94
200-Day MA$27.67
See more pivots

Kymera Therapeutics Inc Stock, NASDAQ:KYMR

200 Arsenal Yards Boulevard, Suite 230, Watertown, Massachusetts 02472
United States of America
Phone: +1.857.285.5300
Number of Employees: 167

Description

Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.